Tenet Healthcare Corporation (THC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $22.76B
Last updated: Nov 17, 2026 at 11:06 AM ET
Tenet Healthcare Corporation (THC) Earnings: Report Dates and Results
Tenet Healthcare (THC) is expected to report earnings on Feb 9, 2027. In the quarter ended Sep 30, 2026, Tenet Healthcare reported EPS of $6.64, above the $4.60 estimate. It beat the EPS estimate in each of the last 34 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
THC has an expected report date of Feb 9, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 13.6% above the $4.70 reported for the quarter ended Dec 31, 2025.
THC Earnings Call
The latest THC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 39 quarters below that had an estimate, THC beat 38 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $5.63B, up 6.4% from $5.29B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $6.64 | $4.60 | $4.03 - $5.11 | +44.35% | Beat | +79.5% | 20 | 1 up, 1 down | Oct 29, 2026 | $5.63B |
| Jun 30, 2026 | $6.12 | $4.08 | $3.58 - $5.17 | +50.00% | Beat | +52.2% | 18 | 1 up, 0 down | Jul 22, 2026 | $5.63B |
| Mar 31, 2026 | $4.82 | $4.17 | $3.08 - $4.66 | +15.59% | Beat | +10.6% | 18 | 1 up, 9 down | Apr 30, 2026 | $5.37B |
| Dec 31, 2025 | $4.70 | $4.07 | $3.66 - $4.29 | +15.48% | Beat | +36.6% | 19 | 4 up, 1 down | Feb 11, 2026 | $5.53B |
| Sep 30, 2025 | $3.70 | $3.35 | $3.12 - $3.76 | +10.45% | Beat | +26.3% | 19 | 2 up, 0 down | Oct 28, 2025 | $5.29B |
| Jun 30, 2025 | $4.02 | $2.87 | $2.51 - $3.15 | +40.07% | Beat | +74.0% | 18 | 5 up, 0 down | Jul 22, 2025 | $5.27B |
| Mar 31, 2025 | $4.36 | $3.13 | $2.85 - $3.44 | +39.30% | Beat | +35.4% | 19 | 1 up, 2 down | Apr 29, 2025 | $5.22B |
| Dec 31, 2024 | $3.44 | $2.83 | $1.48 - $3.08 | +21.45% | Beat | +28.4% | 16 | 4 up, 1 down | Feb 12, 2025 | $5.07B |
| Sep 30, 2024 | $2.93 | $2.37 | $1.67 - $2.64 | +23.63% | Beat | +103.5% | 16 | 15 up, 0 down | Oct 29, 2024 | $5.13B |
| Jun 30, 2024 | $2.31 | $1.91 | $1.61 - $2.52 | +20.94% | Beat | +60.4% | 17 | 4 up, 0 down | Jul 24, 2024 | $5.11B |
| Mar 31, 2024 | $3.22 | $1.44 | $1.04 - $1.56 | +123.61% | Beat | +126.8% | 16 | 1 up, 0 down | Apr 30, 2024 | $5.37B |
| Dec 31, 2023 | $2.68 | $1.62 | N/A | +65.43% | Beat | +36.7% | N/A | N/A | Feb 8, 2024 | $5.38B |
| Sep 30, 2023 | $1.44 | $1.20 | N/A | +20.00% | Beat | 0.0% | N/A | N/A | Oct 30, 2023 | $5.07B |
| Jun 30, 2023 | $1.44 | $1.25 | $0.94 - $1.53 | +15.20% | Beat | -4.0% | 15 | 5 up, 0 down | Jul 31, 2023 | $5.09B |
| Mar 31, 2023 | $1.42 | $1.15 | $0.95 - $1.33 | +23.48% | Beat | -26.4% | 15 | 4 up, 1 down | Apr 25, 2023 | $5.02B |
| Dec 31, 2022 | $1.96 | $1.23 | $0.74 - $1.49 | +59.35% | Beat | -27.4% | 14 | 1 up, 0 down | Feb 9, 2023 | $5.03B |
| Sep 30, 2022 | $1.44 | $1.22 | $0.96 - $1.36 | +18.03% | Beat | -27.6% | 15 | 1 up, 0 down | Oct 20, 2022 | $4.86B |
| Jun 30, 2022 | $1.50 | $0.80 | $0.35 - $1.60 | +87.50% | Beat | -5.7% | 14 | 0 up, 2 down | Jul 21, 2022 | $4.73B |
| Mar 31, 2022 | $1.93 | $1.06 | $0.90 - $1.34 | +82.08% | Beat | +48.5% | 15 | 0 up, 1 down | Apr 20, 2022 | $4.75B |
| Dec 31, 2021 | $2.70 | $1.49 | $1.18 - $2.13 | +81.21% | Beat | -42.8% | 15 | 3 up, 0 down | Feb 7, 2022 | N/A |
| Sep 30, 2021 | $1.99 | $1.08 | $0.73 - $1.69 | +84.26% | Beat | +210.9% | 15 | N/A | Oct 20, 2021 | $4.89B |
| Jun 30, 2021 | $1.59 | $1.07 | $0.93 - $1.27 | +48.60% | Beat | +26.2% | 12 | N/A | Jul 21, 2021 | $4.97B |
| Mar 31, 2021 | $1.30 | $0.72 | $0.34 - $1.10 | +80.56% | Beat | +1.6% | 13 | N/A | Apr 20, 2021 | $4.81B |
| Dec 31, 2020 | $4.72 | $1.81 | $0.47 - $4.05 | +160.77% | Beat | +376.8% | 15 | N/A | Feb 9, 2021 | $9.00B |
| Sep 30, 2020 | $0.64 | $0.24 | -$0.23 - $1.33 | +166.67% | Beat | +10.3% | 16 | N/A | Oct 20, 2020 | $4.49B |
| Jun 30, 2020 | $1.26 | -$0.71 | -$2.17 - $0.67 | +277.46% | Beat | +125.0% | 16 | N/A | Aug 3, 2020 | $511.00M |
| Mar 31, 2020 | $1.28 | $0.37 | -$0.41 - $0.66 | +245.95% | Beat | +137.0% | 17 | N/A | May 4, 2020 | $4.52B |
| Dec 31, 2019 | $0.99 | $0.98 | $0.80 - $1.17 | +1.02% | Beat | +94.1% | 17 | N/A | Feb 24, 2020 | $4.81B |
| Sep 30, 2019 | $0.58 | $0.32 | $0.02 - $0.56 | +81.25% | Beat | +100.0% | 18 | N/A | Nov 4, 2019 | $4.57B |
| Jun 30, 2019 | $0.56 | $0.44 | $0.36 - $0.57 | +27.27% | Beat | +14.3% | 19 | N/A | Aug 5, 2019 | $4.56B |
| Mar 31, 2019 | $0.54 | $0.29 | $0.15 - $0.42 | +86.21% | Beat | -5.3% | 20 | N/A | Apr 29, 2019 | $4.54B |
| Dec 31, 2018 | $0.51 | $0.28 | $0.11 - $0.54 | +82.14% | Beat | -63.6% | 21 | N/A | Feb 25, 2019 | $4.62B |
| Sep 30, 2018 | $0.29 | $0.12 | $0.04 - $0.24 | +141.67% | Beat | N/A | 17 | N/A | Nov 5, 2018 | $4.49B |
| Jun 30, 2018 | $0.49 | $0.23 | $0.15 - $0.47 | +113.04% | Beat | N/A | 16 | N/A | Aug 6, 2018 | $4.51B |
| Mar 31, 2018 | $0.57 | -$0.04 | -$0.53 - $0.04 | N/A | N/A | N/A | 12 | N/A | Apr 30, 2018 | $4.70B |
| Dec 31, 2017 | $1.40 | $1.24 | $1.05 - $1.36 | +12.90% | Beat | +2233.3% | 16 | N/A | Feb 26, 2018 | $5.30B |
| Sep 30, 2017 | -$0.17 | -$0.43 | -$0.60 - -$0.24 | +60.47% | Beat | -206.3% | 13 | N/A | Oct 27, 2017 | $4.94B |
| Jun 30, 2017 | -$0.17 | -$0.18 | -$0.38 - $0.05 | +5.56% | Beat | -144.7% | 18 | N/A | Aug 7, 2017 | $5.17B |
| Mar 31, 2017 | -$0.27 | -$0.52 | N/A | +48.08% | Beat | -160.0% | N/A | N/A | May 1, 2017 | $5.20B |
| Dec 31, 2016 | $0.06 | $0.22 | N/A | -72.73% | Miss | -82.9% | N/A | N/A | Feb 27, 2017 | $5.21B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $16.78, up 41.0% from the year before. It was $1.05 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $16.78 | +41.0% |
| Dec 31, 2024 | $11.90 | +70.5% |
| Dec 31, 2023 | $6.98 | +2.2% |
| Dec 31, 2022 | $6.83 | -9.9% |
| Dec 31, 2021 | $7.58 | -4.1% |
| Dec 31, 2020 | $7.90 | +195.9% |
| Dec 31, 2019 | $2.67 | +43.5% |
| Dec 31, 2018 | $1.86 | +135.4% |
| Dec 31, 2017 | $0.79 | -24.8% |
| Dec 31, 2016 | $1.05 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 19 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,197 | 19 | |
| 2026Q2 | Jun 30, 2026 | 7,593 | 17 | |
| 2026Q1 | Mar 31, 2026 | 5,192 | 17 | |
| 2025Q4 | Dec 31, 2025 | 7,246 | 20 | |
| 2025Q3 | Sep 30, 2025 | 5,436 | 17 | |
| 2025Q2 | Jun 30, 2025 | 6,758 | 18 | |
| 2025Q1 | Mar 31, 2025 | 7,090 | 18 | |
| 2024Q4 | Dec 31, 2024 | 6,830 | 20 |
2026Q3 Earnings Call
Opening remarks
William McDowell Vice President of Investor Relations Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We are pleased to have you join us for a discussion of Tenet's third quarter 2026 results, as well as a discussion of our financial outlook. Tenet senior management participating in today's call will be Dr. Saumya Sutaria, Chairman and Chief Executive Officer, and Sun K. Park, Executive Vice President and Chief Financial Officer. The webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com. Listeners to this call are advised that certain statements made during our discussion today are forward-looking and represent management's expectations based on currently available information. Actual results and plans could differ materially. Tenet is under no obligation to update any forward-looking statements based on subsequent information. Investors should take note of the cautionary statement slide included in today's presentation, as well as the risk factors discussed in our most recent Form 10-Ks and other filings with the Securities and Exchange Commission. With that, I will turn the call over to Saumya.
Saumya Sutaria Chairman and Chief Executive Officer Thank you, Will, and good morning, everyone. Third quarter net operating revenues were $5.6 billion, and consolidated adjusted EBITDA was $1.355 billion. Adjusted diluted earnings per share increased 80% to $6.40 in the third quarter of 2026 compared to the prior year. More importantly, after adjusting for one-time items related to contract transitions that generated adjusted EBITDA of $147 million that was not reflected in our previous guidance, the core business continued its strong growth trajectory in 2026, with an adjusted EBITDA margin of 21.8% and growth in adjusted EBITDA over the third quarter of 2025. We continue to manage through payer mix shifts and enrollment declines in the exchanges, and execute on our technology-enabled growth and expense management plans that support our margin strength. Our strong performance is driving significant free cash flow that we continue to deploy for the benefit of shareholders. Year to date, we have deployed over $1.6 billion for share repurchases. Now turning to our segments, USPI generated $537 million in adjusted EBITDA, which represents 9% growth over the third quarter of 2025. Same-facility revenues grew 4.5%, as our high-acuity strategy continues to yield benefits and is highlighted by our strongest quarterly performance this year, with 12.8% same-store growth in total joint replacements in the ASCs over the prior year. USPI also had a very successful quarter in development, with over $100 million of investments in the third quarter alone. We remain the preferred acquirer of assets in this space and continue to have an attractive pipeline of partnerships interested in joining USPI.
Frequently Asked Questions About THC
When is Tenet Healthcare's next earnings date?
Tenet Healthcare's next earnings report is expected for Feb 9, 2027.
Did THC beat earnings estimates last quarter?
Yes. Tenet Healthcare reported EPS of $6.64 for the quarter ended Sep 30, 2026, above the $4.60 estimate, a 44.35% surprise.
What EPS do analysts expect from THC next quarter?
The consensus EPS estimate for Tenet Healthcare for the quarter ending Dec 31, 2026 is $5.34 from 22 analysts, with estimates from $4.38 to $6.39.
How often does THC beat earnings estimates?
Tenet Healthcare beat the EPS estimate in each of the last 34 quarters, with an average surprise of +72.18%.
THC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts